Price cap models in pharmaceutical online-to-offline supply chains
Summary: Pharmaceutical supply chains are often highly complex with conflicting objectives of social welfare and profit maximization. Furthermore, there are various stakeholders including pharmaceutical manufacturer, distributors, retailers, patients, and the government. In this paper, we consider a two-stage supply chain consisting of one pharmaceutical manufacturer and a pharmacy with online and offline channels. We focus on four price cap models: no price cap regulation, pharmaceutical manufacturer's price cap regulation, pharmacy price cap regulation, and linkage price cap regulation. We apply game theory, investigate how the price cap regulations affect the firms' pricing, and evaluate the economic performance and social welfare of the dual-channel pharmaceutical supply chain. Our findings show that first, like the single-channel pharmaceutical supply chain, the profit of the regulated firm always decreases and the profit of the unregulated firm always increases when they are under one-sided price cap regulations. Second, the impacts of the linkage price cap regulation on the supply chain are more complicated depending on the linkage coefficient and market share. Overall, our findings can provide theoretical and practical insights to help the government devise price cap regulations for complex modern pharmaceutical supply chains.
- Pharmaceutical supply chain networks with outsourcing under price and quality competition
- Impact of price cap regulation on supply chain contracting between two monopolists
- Coordination contract for a competitive pharmaceutical supply chain considering corporate social responsibility and pricing decisions
- A structured review of quantitative models of the pharmaceutical supply chain
- Complexity of a dynamic hybrid supply chain game model with a service factor
- A structured review of quantitative models of the pharmaceutical supply chain
- Analysis of firm CSR strategies
- Contract type and decision right of sales promotion in supply chain management with a capital constrained retailer
- Dynamic VRP in pharmaceutical distribution -- a case study
- Evaluation and selection of manufacturing suppliers in B2B E-commerce environment
- Introduction of a second channel: Implications for pricing and profits
- Pharmaceutical supply chain networks with outsourcing under price and quality competition
- Pricing and supply priority in a dual-channel supply chain
- The optimal pricing of dual-channel supply chain with the third party product recovery and sales effort
This page was built for publication: Price cap models in pharmaceutical online-to-offline supply chains
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2221983)
